The cost of GLP-1s needs to come way down for benefits to be worth it, study saysByBruce GilPublishedMarch 17, 2025
The weight loss drug shortage is over — and some patients are 'panicking'ByBruce GilPublishedMarch 17, 2025
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundupByBruce GilPublishedMarch 14, 2025
Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down todayByBruce GilUpdatedThursday 12:48PM
Lawmakers demand answers from RFK Jr. over Trump dinners with pharma execsByBruce GilPublishedMarch 11, 2025
Viking Therapeutics closer to bringing its Ozempic competitor to marketByBruce GilUpdatedMarch 11, 2025
